• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[乳腺癌中的激素模式]

[Hormonal patterns in breast cancers].

作者信息

Kiricuta I, Frenkel Z, Munteanu S

出版信息

Arch Geschwulstforsch. 1974;44(3):260-6.

PMID:4460955
Abstract

Urinary outpout of oestrogens and 17-ketosteroids were estimated in 200 women with breast cancer; 60 of them were cases with rapid evolution (malignant evolutive push). The majority of cases analysed had abnormal hormonal levels, especially of oestrogens. The average oestrogenic levels are higher than the normal values; the highest values correspond to the most severe and rapidly evolutive type of breast cancer, the inflammatory breast carcinoma. In the patients without evolutive push, the proportion of cases with absolute or relative hypooestrogeny is approximately equal toor exceeds the proportion of hyperoestrogenic cases. In the presence of the evolutive push and especially of his most severe type, inflammatory carcinoma, the cases with hyperoestrogeny, both absolute and relative, by hypoandrogeny, are dominant. The proportion of cases with higher 17-ketosteroid urinary outputs than the normal mean is greater in the patients without evolutive push, while in those with evolutive push, the majority of cases have lower values of 17-ketosteroids than the normal mean.

摘要

对200例乳腺癌女性患者的雌激素和17 - 酮类固醇尿排泄量进行了评估;其中60例为快速进展型(恶性进展性侵袭)病例。大多数分析病例的激素水平异常,尤其是雌激素。雌激素平均水平高于正常值;最高值对应最严重且进展迅速的乳腺癌类型,即炎性乳腺癌。在无进展性侵袭的患者中,绝对或相对雌激素缺乏病例的比例约等于或超过雌激素过多病例的比例。在存在进展性侵袭尤其是其最严重类型炎性癌的情况下,绝对和相对雌激素过多伴雄激素缺乏的病例占主导。17 - 酮类固醇尿排泄量高于正常均值的病例比例在无进展性侵袭的患者中更大,而在有进展性侵袭的患者中,大多数病例的17 - 酮类固醇值低于正常均值。

相似文献

1
[Hormonal patterns in breast cancers].[乳腺癌中的激素模式]
Arch Geschwulstforsch. 1974;44(3):260-6.
2
Levels of principal 17-ketosteroid fractions in urine of breast cancer patients with or without malignant evolutive push.有或无恶性进展倾向的乳腺癌患者尿液中主要17-酮类固醇组分的水平。
Arch Geschwulstforsch. 1978;48(6):565-8.
3
Clinical and hormonal aspects in breast cancer with special reference to malignant evolutive push.乳腺癌的临床和激素方面,特别提及恶性进展趋势。
Arch Geschwulstforsch. 1975;45(5):464-72.
4
Some aspects of the endocrine status in the inflammatory breast carcinoma (Mastitis carcinosa).炎性乳腺癌(癌性乳腺炎)内分泌状态的某些方面。
Arch Geschwulstforsch. 1982;52(1):67-73.
5
[Steroid balance in breast cancers of varying histological structure].[不同组织学结构乳腺癌中的类固醇平衡]
Vopr Onkol. 1980;26(9):37-41.
6
Urinary steroid hormones in normal Japanese women and primary breast cancer patients.正常日本女性和原发性乳腺癌患者的尿甾体激素
Nihon Gan Chiryo Gakkai Shi. 1978 Dec 20;13(6):663-75.
7
Urinary excretion of 17-ketosteroids in patients suffering from mammary cancer.乳腺癌患者的17-酮类固醇尿排泄量
Arch Geschwulstforsch. 1975;45(5):457-63.
8
[The relationship between the course of mammary gland cancer and age and hormonal features of the body].[乳腺癌病程与年龄及机体激素特征之间的关系]
Vopr Onkol. 1969;15(5):73-7.
9
[Study on the hormonal etiology of breast cancer and atypical endometrial hyperplasia in women of pre-menopausal age].
Cancro. 1973;26(1):3-13.
10
[Endolumbar administration of hydrocortisone in the complex treatment of patients with generalized breast cancer].[氢化可的松经腰给药在广泛性乳腺癌患者综合治疗中的应用]
Vopr Onkol. 1975;21(5):99-104.